Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes.

Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Abstract Text:

    haitao chuHaitao Chu,stephen r coleStephen R Cole,

    The novel two-step serologic sensitive/less sensitive testing algorithm for detecting recent HIV seroconversion (STARHS) provides a simple and practical method to estimate HIV-1 incidence using cross-sectional HIV seroprevalence data. STARHS has been used increasingly in epidemiologic studies. However, the uncertainty of incidence estimates using this algorithm has not been well described, especially for high risk groups or when missing data is present because a fraction of sensitive enzyme immunoassay (EIA) positive specimens are not tested by the less sensitive EIA. Ad hoc methods used in practice provide incorrect confidence limits and thus may jeopardize statistical inference. In this report, we propose maximum likelihood and Bayesian methods for correctly estimating the uncertainty in incidence estimates obtained using prevalence data with a fraction missing, and extend the methods to regression settings. Using a study of injection drug users participating in a drug detoxification program in New York city as an example, we demonstrated the impact of underestimating the uncertainty in incidence estimates using ad hoc methods. Our methods can be applied to estimate the incidence of other diseases from prevalence data using similar testing algorithms when missing data is present.

    Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Publishing Authors By Initials

    h chuH Chu,sr coleSR Cole,

    For similar disorders of environmental origin: substance-related disorders: substance abuse, intravenous research abstracts see: disorders of environmental origin: substance-related disorders: substance abuse, intravenous research

    PUBMED ID PMID:

    MEDLINE DATE:

    Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Biometrical journal. Biometrische Zeitschrift

    VOLUME: 48

    Page Numbers: 772-9

    Journal Abbreviation:

    ISSN: 0323-3847

    DAY: 3

    MONTH: Aug

    YEAR: 2006

    Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7708048

    Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Keywords Mesh Terms:

    KEYWORDS: Substance Abuse, Intravenous

    MESH TERMS: virology

    Chemical & Substance for Abstract: Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes. Information

    Substance Name: HIV Antibodies

    Registry Number: 0

    Grant and Affiliation Information for Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes.

    AFFILIATION: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. hchu@jhsph.edu

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY: United States NIAID

    GRANT: U01-AI-42590

    ACRONYM: AI

    MEDLINETA: Biom J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News